ConductScience.org, home

Paper19253922

Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.

Huang YF and 6 others. Chembiochem, 2009. Cited by 306 papers, by iCite.

Cite this record

ConductScience Library. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Papers, record 19253922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19253922

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
PubMed
Journal
Chembiochem
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
306
iCite
Relative citation ratio, by iCite
7.51
iCite
Revised in PubMed
2025-05-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang YFYu-Fen
2Shangguan DDihua
3Liu HHaipeng
4Phillips JAJoseph A
5Zhang XXiaoling
6Chen YYan
7Tan WWeihong

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Aptamers, NucleotideMajor topic
DoxorubicinMajor topic
Drug Delivery SystemsMajor topic
NeoplasmsMajor topic
SELEX Aptamer TechniqueMajor topic
Animals
Base Sequence
Cell Line, Tumor
Drug Carriers
Endocytosis
Humans
Immunoconjugates
Molecular Sequence Data
Molecular Structure

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 GM079359NIGMS NIH HHSUnited StatesR01GM079359PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116778167Aptamer:toxin conjugates that specifically target prostate tumor cells.Cancer Res2006https://conductscience.org/library/papers/16778167PubMed
217099918An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform.Angew Chem Int Ed Engl2006https://conductscience.org/library/papers/17099918PubMed
312676579Progress in immunoconjugate cancer therapeutics.Cancer Cell2003https://conductscience.org/library/papers/12676579PubMed
415828758Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions.Anal Chem2005https://conductscience.org/library/papers/15828758PubMed
518536555Antibody-drug conjugates for cancer therapy.Cancer J2008https://conductscience.org/library/papers/18536555PubMed
68564396Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro.Bioorg Med Chem1995https://conductscience.org/library/papers/8564396PubMed
714676325A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/14676325PubMed
81697402In vitro selection of RNA molecules that bind specific ligands.Nature1990https://conductscience.org/library/papers/1697402PubMed
96300903pH and the recycling of transferrin during receptor-mediated endocytosis.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6300903PubMed
1017463173Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.Clin Chem2007https://conductscience.org/library/papers/17463173PubMed
1116640493Nanoparticle-aptamer bioconjugates for cancer targeting.Expert Opin Drug Deliv2006https://conductscience.org/library/papers/16640493PubMed
1218177018Identification of liver cancer-specific aptamers using whole live cells.Anal Chem2008https://conductscience.org/library/papers/18177018PubMed
137508268(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.Bioconjug Chem1993https://conductscience.org/library/papers/7508268PubMed
1417705444Targeted cancer therapy: conferring specificity to cytotoxic drugs.Acc Chem Res2008https://conductscience.org/library/papers/17705444PubMed
1516873550Aptamers evolved from live cells as effective molecular probes for cancer study.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16873550PubMed
1618363322Cell-specific aptamer probes for membrane protein elucidation in cancer cells.J Proteome Res2008https://conductscience.org/library/papers/18363322PubMed
1718092308Cell-specific internalization study of an aptamer from whole cell selection.Chemistry2008https://conductscience.org/library/papers/18092308PubMed
182200121Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.Science1990https://conductscience.org/library/papers/2200121PubMed
1918163537Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage.Bioconjug Chem2008https://conductscience.org/library/papers/18163537PubMed
2011279054Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen.J Biol Chem2001https://conductscience.org/library/papers/11279054PubMed

See all 24 referencesDownload CSV of references

Cited by149

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 306 citations.

PMIDTitleJournalYearIn PapersSource
42706252Nucleic acid aptamers: new methods for selection, target validation, molecular diagnostics and therapeutics.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42706252PubMed
42559290Antibody-Drug Conjugates and Peptide-Drug Conjugates: Current Understandings and Future Perspectives.MedComm (2020)2026https://conductscience.org/library/papers/42559290PubMed
42371418A CD36-targeted aptamer-4-butyl-polyhydroxybenzophenone conjugate with pH-responsive release for liver delivery in MASLD.Regen Biomater2026https://conductscience.org/library/papers/42371418PubMed
42294300Synthetic short RNA in cancer.Front Oncol2026https://conductscience.org/library/papers/42294300PubMed
41820318Aptamers in Osteosarcoma: New Paths for Diagnosis and Treatment.Anticancer Agents Med Chem2026https://conductscience.org/library/papers/41820318PubMed
41754959CD25-Targeted Aptamer-Drug Conjugate for the Treatment of CD25-Expressing Hematological Malignancies.Pharmaceutics2026https://conductscience.org/library/papers/41754959PubMed
41306923Aptamers in Drug Delivery Development.Mater Today (Kidlington)2025https://conductscience.org/library/papers/41306923PubMed
41190338Covalent aptamers: agents with promising therapeutic and diagnostic potential.RSC Chem Biol2026https://conductscience.org/library/papers/41190338PubMed
40987771An aptamer-drug conjugate for promising cancer therapy with comprehensive evaluation from rodents to non-human primates.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40987771PubMed
40925520Aptamers as target-specific recognition elements in drug delivery.Adv Drug Deliv Rev2025https://conductscience.org/library/papers/40925520PubMed
40870970Aptamers Targeting Immune Checkpoints for Tumor Immunotherapy.Pharmaceutics2025https://conductscience.org/library/papers/40870970PubMed
40563458Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery.Biomolecules2025https://conductscience.org/library/papers/40563458PubMed
40397061Improvement of Drug Release from an Aptamer Drug Conjugate Using Reductive-sensitive Linkers for Tumor-targeted Drug Delivery.AAPS J2025https://conductscience.org/library/papers/40397061PubMed
39572459Dual roles of extracellular vesicles in acute lymphoblastic leukemia: implications for disease progression and theranostic strategies.Med Oncol2024https://conductscience.org/library/papers/39572459PubMed
39434968Progressive cancer targeting by programmable aptamer-tethered nanostructures.MedComm (2020)2024https://conductscience.org/library/papers/39434968PubMed
38493153Aptamers as an approach to targeted cancer therapy.Cancer Cell Int2024https://conductscience.org/library/papers/38493153PubMed
38391997Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims.Biosensors (Basel)2024https://conductscience.org/library/papers/38391997PubMed
38051194Enzymatic Synthesis of Aptamer-Polynucleotide Nanoparticles with High Anticancer Drug Loading for Targeted Delivery.Biomacromolecules2024https://conductscience.org/library/papers/38051194PubMed
37720779Recent Advancements of Aptamers in Cancer Therapy.ACS Omega2023https://conductscience.org/library/papers/37720779PubMed
37538812Mechanics of dynamic and deformable DNA nanostructures.Chem Sci2023https://conductscience.org/library/papers/37538812PubMed

See all 149 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD33945PubTator's text mininghttps://conductscience.org/library/genes/945NCBI Gene
FOLH12346PubTator's text mininghttps://conductscience.org/library/genes/2346NCBI Gene
PTK75754PubTator's text mininghttps://conductscience.org/library/genes/5754NCBI Gene
TF7018PubTator's text mininghttps://conductscience.org/library/genes/7018NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19253922

GET https://conductscience.org/api/papers/v1/19253922/references?page=2